CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 256 filers reported holding CYTOKINETICS INC in Q3 2023. The put-call ratio across all filers is 2.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $353,249,689 | -11.0% | 11,990,824 | -1.4% | 0.03% | -6.1% |
| Q2 2023 | $396,756,032 | -56.2% | 12,162,968 | -52.7% | 0.03% | -19.5% |
| Q1 2023 | $905,425,504 | +47.9% | 25,729,624 | +92.6% | 0.04% | -32.8% |
| Q4 2022 | $612,153,258 | -2.0% | 13,359,958 | +3.7% | 0.06% | -6.2% |
| Q3 2022 | $624,457,000 | +24.1% | 12,888,671 | +0.7% | 0.06% | +30.0% |
| Q2 2022 | $503,063,000 | +7.6% | 12,803,861 | +0.8% | 0.05% | +35.1% |
| Q1 2022 | $467,722,000 | -18.2% | 12,706,366 | +1.3% | 0.04% | -11.9% |
| Q4 2021 | $571,598,000 | +28.1% | 12,540,549 | +0.4% | 0.04% | +20.0% |
| Q3 2021 | $446,215,000 | +165.6% | 12,485,007 | +47.1% | 0.04% | +169.2% |
| Q2 2021 | $167,991,000 | +88.0% | 8,488,682 | +121.0% | 0.01% | +62.5% |
| Q1 2021 | $89,357,000 | +314.4% | 3,841,703 | +270.3% | 0.01% | +300.0% |
| Q4 2020 | $21,561,000 | -70.3% | 1,037,571 | -69.1% | 0.00% | -71.4% |
| Q3 2020 | $72,649,000 | -12.2% | 3,355,621 | -4.4% | 0.01% | -22.2% |
| Q2 2020 | $82,703,000 | +139.2% | 3,508,847 | +19.7% | 0.01% | +80.0% |
| Q1 2020 | $34,575,000 | +82.8% | 2,932,498 | +64.5% | 0.01% | +150.0% |
| Q4 2019 | $18,918,000 | -1.2% | 1,783,125 | +6.0% | 0.00% | 0.0% |
| Q3 2019 | $19,152,000 | +2.0% | 1,682,917 | +0.9% | 0.00% | 0.0% |
| Q2 2019 | $18,773,000 | +20.4% | 1,668,695 | -13.4% | 0.00% | 0.0% |
| Q1 2019 | $15,589,000 | +33.1% | 1,926,824 | +3.9% | 0.00% | 0.0% |
| Q4 2018 | $11,715,000 | -39.2% | 1,853,683 | -5.2% | 0.00% | 0.0% |
| Q3 2018 | $19,271,000 | +23.1% | 1,956,383 | +3.7% | 0.00% | 0.0% |
| Q2 2018 | $15,652,000 | -5.2% | 1,885,752 | -17.7% | 0.00% | 0.0% |
| Q1 2018 | $16,506,000 | -12.6% | 2,292,452 | -1.1% | 0.00% | 0.0% |
| Q4 2017 | $18,888,000 | -71.0% | 2,317,552 | -48.4% | 0.00% | -75.0% |
| Q3 2017 | $65,104,000 | +16.3% | 4,489,946 | -3.0% | 0.01% | +14.3% |
| Q2 2017 | $55,984,000 | -23.0% | 4,626,746 | -18.2% | 0.01% | -22.2% |
| Q1 2017 | $72,679,000 | +15.0% | 5,655,916 | +8.8% | 0.01% | +12.5% |
| Q4 2016 | $63,173,000 | +35.9% | 5,199,414 | +2.7% | 0.01% | +33.3% |
| Q3 2016 | $46,475,000 | +48.1% | 5,062,656 | +53.1% | 0.01% | +50.0% |
| Q2 2016 | $31,391,000 | +110.0% | 3,307,822 | +56.0% | 0.00% | +100.0% |
| Q1 2016 | $14,945,000 | -33.5% | 2,119,797 | -1.3% | 0.00% | -33.3% |
| Q4 2015 | $22,470,000 | +76.5% | 2,148,197 | +12.9% | 0.00% | +50.0% |
| Q3 2015 | $12,728,000 | -35.9% | 1,902,482 | -35.6% | 0.00% | -33.3% |
| Q2 2015 | $19,852,000 | +1.7% | 2,954,259 | +2.6% | 0.00% | +50.0% |
| Q1 2015 | $19,513,000 | -10.9% | 2,878,038 | +5.3% | 0.00% | -33.3% |
| Q4 2014 | $21,892,000 | +94.0% | 2,733,186 | -14.8% | 0.00% | +50.0% |
| Q3 2014 | $11,286,000 | -23.4% | 3,206,401 | +4.0% | 0.00% | 0.0% |
| Q2 2014 | $14,738,000 | -25.3% | 3,083,356 | +48.5% | 0.00% | -33.3% |
| Q1 2014 | $19,721,000 | +62.1% | 2,075,876 | +10.9% | 0.00% | +50.0% |
| Q4 2013 | $12,167,000 | -13.4% | 1,871,916 | +1.1% | 0.00% | 0.0% |
| Q3 2013 | $14,050,000 | – | 1,851,135 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,106,989 | $14,159,000 | 2.50% |
| Healthcare Value Capital, LLC | 100,000 | $672,000 | 0.71% |
| First Light Asset Management, LLC | 218,792 | $1,470,000 | 0.69% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 435,202 | $2,925,000 | 0.67% |
| TFS CAPITAL LLC | 899,951 | $6,048,000 | 0.59% |
| SPHERA FUNDS MANAGEMENT LTD. | 422,250 | $2,838,000 | 0.28% |
| ALGERT GLOBAL LLC | 73,181 | $492,000 | 0.27% |
| LANSDOWNE PARTNERS (UK) LLP | 2,321,865 | $15,603,000 | 0.13% |
| Leisure Capital Management | 17,567 | $118,000 | 0.12% |
| Rotella Capital Management, Inc. | 15,778 | $106,000 | 0.09% |